A Study of Combination of Daratumumanb and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants with Previously Untreated Multiple Myeloma

Update Il y a 4 ans
Reference: EUCTR2014-002272-88

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective is to determine if the addition of daratumumab to VMP will prolong PFS compared with VMP.


Inclusion criteria

  • Multiple myeloma